Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients

New England Journal of Medicine

Volumn 335, Issue 3, 1996, Pages 157-166

  Kurtzberg, Joanne ^a   Laughlin, Mary ^a   Graham, Michael L ^a   Smith, Clay ^a   Olson, Janice F ^a   Halperin, Edward C ^a   Ciocci, Gilbert ^a   Carrier, Carmelita ^b   Stevens, Cladd E ^b   Rubinstein, Pablo ^b  

^a DUKE UNIVERSITY   (United States)

^b NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD BANK; BLOOD DONOR; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HLA MATCHING; HLA TYPING; HUMAN; INFANT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MITOGENESIS; PLACENTA; PRIORITY JOURNAL; RECIPIENT; UMBILICAL CORD BLOOD;

ADOLESCENT; ADULT; BLOOD BANKS; BLOOD DONORS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FETAL BLOOD; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; MALE; PLACENTA; SURVIVAL RATE;

EID: 8944228913     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199607183350303     Document Type: Article

References (44)

1. Gluckman E. Bone marrow transplantation in Fanconi's anemia. Stem Cells 1993;11:Suppl 2:180-3.
2. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993;328:593-602.
3. Storb R, Thomas ED, Buckner CD, et al. Marrow transplantation for aplastic anemia. Semin Hematol 1984;21:27-35.
4. Champlin RE, Ho WG, Nimer SD, et al. Bone marrow transplantation for severe aplastic anemia: effect of a preparative regimen of cyclophosphamide-low-dose total-lymphoid irradiation and posttransplant cyclosporine-methotrexate therapy. Transplantation 1990;49:720-4.
5. McGlave PB, Haake R, Miller W, Kim T, Kersey J, Ramsay NK. Therapy of severe aplastic anemia in young adults and children with allogeneic bone marrow transplantation. Blood 1987;70:1325-30.
6. Storb R, Sanders JE, Pepe M, et al. Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts. Blood 1991;78:1144-5.
7. Storb R, Pepe M, Anasetti C, et al. What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants? Blood 1990;76:1037-45.
8. Chao NJ, Schmidt GM, Niland JC, et al. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. N Engl J Med 1993;329:1225-30.
9. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15:825-8.
10. Howard MR, Gore SM, Hows JM, Downie TR, Bradley BA. A prospective study of factors determining the outcome of unrelated marrow donor searches: report from The International Marrow Unrelated Search and Transplant Study Working Group on behalf of collaborating centres. Bone Marrow Transplant 1994;13:389-96.
11. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995;346:214-9.
12. Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from a HLA-identical sibling. N Engl J Med 1989;321:1174-8.
13. Kurtzberg J, Graham M, Casey J, Olson J, Stevens CE, Rubinstein P. The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. Blood Cells 1994;20:275-84.
14. Vilmer E, Sterkers G, Rahimy C, et al. HLA-mismatched cord blood transplantation in a patient with advanced leukemia. Bone Marrow Transplant 1991;7:Suppl 2:125.
15. Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE. Stored placental blood for unrelated bone marrow reconstitution. Blood 1993;81:1679-90.
16. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995;92:10119-22.
17. Gluckman E, Socie G, Devergie A, Bourdeau-Esperou H, Traineau R, Cosset JM. Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoraco-abdominal irradiation for conditioning: long-term follow-up. Blood 1991;78:2451-5.
18. Balcarek KB, Warren W, Smith RJ, Lyon MD, Pass RF. Neonatal screening for congenital cytomegalovirus infection by detection of virus in saliva. J Infect Dis 1993;167:1433-6.
19. Emanuel D, Cunningham I, Jules-Elysee K, et al. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med 1988;109:777-82.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
21. Peacock JE Jr, Greven CM, Cruz JM, Hurd DD. Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis? Bone Marrow Transplant 1995; 15:983-7.
22. Samuels BL, Bitran JD. High-dose intravenous melphalan: a review. J Clin Oncol 1995;13:1786-99.
23. Powles RL, Milliken S, Helenglass G, et al. The use of melphalan in conjunction with total body irradiation as treatment for acute leukaemia. Transplant Proc 1989;21:2955-7.
24. Carey PJ, Proctor SJ, Taylor P, Hamilton PJ. Autologous bone marrow transplantation for high-grade lymphoid malignancy using melphalan/irradiation conditioning without marrow purging or cryopreservation. Blood 1991;77:1593-8.
25. Gandola L, Lombardi F, Siena S, et al. Total body irradiation and high-dose melphalan with bone marrow transplantation at Istituto Nazionale Tumori, Milan, Italy. Radiother Oncol 1990;18:Suppl 1:105-9.
26. Schroeder H, Pinkerton CR, Powles RL, et al. High dose melphalan and total body irradiation with autologous marrow rescue in childhood acute lymphoblastic leukaemia after relapse. Bone Marrow Transplant 1991;7:11-5.
27. Keating A, Crump M. High dose etoposide melphalan, total body irradiation and ABMT for acute myeloid leukemia in first remission. Leukemia 1992;6:Suppl 4:90-1.
28. Phillips GL, Shepherd JD, Barnett MJ, et al. Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy. J Clin Oncol 1991;9:1880-8.
29. Russell S, Vowels M. Busulfan, cyclophosphamide, and melphalan as conditioning therapy in allogeneic bone marrow transplants for acute lymphoblastic leukemia. Transplant Proc 1992;24:183.
30. Wingard JR, Plotnick LP, Freemer CS, et al. Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood 1992;79:1068-73.
31. Broxmeyer HE. Self-renewal and migration of stem cells during embryonic and fetal hematopoiesis: important, but poorly understood events. Blood Cells 1991;17:282-6.
32. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 1989;86:3828-32.
33. Broxmeyer HE, Hangoc G, Cooper S, et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci U S A 1992;89:4109-13.
34. Lu L, Xiao M, Shen RN, Grigsby S, Broxmeyer HE. Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 1993;81:41-8.
35. Hows JM, Bradley BA, Marsh JCW, et al. Growth of human umbilical-cord blood in longterm haemopoietic cultures. Lancet 1992;340:73-6.
36. Hirao A, Kawano Y, Takauc Y, et al. Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system. Exp Hematol 1994;22:521-6.
37. Migliaccio G, Migliaccio AR, Druzin ML, Giardina PJ, Zsebo KM, Adamson JW. Long-term generation of colony-forming cells in liquid culture of CD34+ cord blood cells in the presence of recombinant human stem cell factor. Blood 1992;79:2620-7.
38. Gabutti V, Timeus F, Ramenghi U, et al. Human cord blood progenitors: kinetics, regulation and their use for hemopoietic reconstitution. Bone Marrow Transplant 1993;12:Suppl 1:84-6.
39. Wang XH, Zipursky A. Maternal erythrocytes in the fetal circulation: the immunocytochemical identification of minor populations of erythrocytes. Am J Clin Pathol 1987;88:346-8.
40. Cohen F, Zuelzer WW. The transplacental passage of maternal erythrocytes into the fetus. Am J Obstet Gynecol 1965;93:566-9.
41. O'Reilly RJ, Patterson JH, Bach FH, et al. Chimerism detected by HL-A typing. Transplantation 1973;15:505-7.
42. Pollack MS, Kapoor N, Sorell M, et al. DR-positive maternal engrafted T cells in a severe combined immunodeficiency patient without graft-versus-host disease. Transplantation 1980;30:331-4.
43. Pollack MS, Kirkpatrick D, Kapoor N, Dupont B, O'Reilly RJ. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med 1982; 307:662-6.
44. Risdon G, Gaddy J, Stehman FB, Broxmeyer HE. Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation. Cell Immunol 1994;154:14-24.